Monitoring JAK2V617F allele burden in patients with essential thrombocythemia reveals implications for disease transformation.
An increasing JAK2V617F allele burden over time is associated with disease transformation in ET, supporting the need for the ongoing monitoring of JAK2V617F VAF in these patients.
No takes yet. Share an insight, caveat, or question.
Koh et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: